Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Alimera Sciences Q2 EPS $(1.32) Misses $0.06 Estimate, Sales $17.54M Miss $20.36M Estimate

Author: Benzinga Newsdesk | August 10, 2023 07:32am
Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(1.32) per share which missed the analyst consensus estimate of $0.06 by 2300 percent. This is a 193.33 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $17.54 million which missed the analyst consensus estimate of $20.36 million by 13.86 percent. This is a 20.09 percent increase over sales of $14.60 million the same period last year.

Posted In: ALIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist